spacer
spacer

PDBsum entry 1h1p

Go to PDB code: 
Top Page protein ligands Protein-protein interface(s) links
Transferase PDB id
1h1p
Contents
Protein chains
297 a.a. *
258 a.a. *
Ligands
CMG ×2
Waters ×410
* Residue conservation analysis

References listed in PDB file
Key reference
Title Structure-Based design of a potent purine-Based cyclin-Dependent kinase inhibitor.
Authors T.G.Davies, J.Bentley, C.E.Arris, F.T.Boyle, N.J.Curtin, J.A.Endicott, A.E.Gibson, B.T.Golding, R.J.Griffin, I.R.Hardcastle, P.Jewsbury, L.N.Johnson, V.Mesguiche, D.R.Newell, M.E.Noble, J.A.Tucker, L.Wang, H.J.Whitfield.
Ref. Nat Struct Biol, 2002, 9, 745-749. [DOI no: 10.1038/nsb842]
PubMed id 12244298
Abstract
Aberrant control of cyclin-dependent kinases (CDKs) is a central feature of the molecular pathology of cancer. Iterative structure-based design was used to optimize the ATP- competitive inhibition of CDK1 and CDK2 by O(6)-cyclohexylmethylguanines, resulting in O(6)-cyclohexylmethyl-2-(4'- sulfamoylanilino)purine. The new inhibitor is 1,000-fold more potent than the parent compound (K(i) values for CDK1 = 9 nM and CDK2 = 6 nM versus 5,000 nM and 12,000 nM, respectively, for O(6)-cyclohexylmethylguanine). The increased potency arises primarily from the formation of two additional hydrogen bonds between the inhibitor and Asp 86 of CDK2, which facilitate optimum hydrophobic packing of the anilino group with the specificity surface of CDK2. Cellular studies with O(6)-cyclohexylmethyl-2-(4'- sulfamoylanilino) purine demonstrated inhibition of MCF-7 cell growth and target protein phosphorylation, consistent with CDK1 and CDK2 inhibition. The work represents the first successful iterative synthesis of a potent CDK inhibitor based on the structure of fully activated CDK2-cyclin A. Furthermore, the potency of O(6)-cyclohexylmethyl-2-(4'- sulfamoylanilino)purine was both predicted and fully rationalized on the basis of protein-ligand interactions.
Figure 1.
Figure 1. Inhibitor structures and binding of NU2058 to T160pCDK2 -cyclinA. a, Chemical structures of NU2058, NU6094, NU6086 and NU6102. b, T160pCDK2 -cyclinA -NU2058 structure. T160pCDK2 -cyclinA is drawn in ribbon representation. CDK2 is purple and cyclin A is gold. NU2058 bound in the CDK2 active site cleft is shown as a surface representation in green. c, CDK2 -NU2058 hydrogen bond interactions. Schematic representation of the conserved hydrogen bonds between backbone atoms of CDK2 residues Leu 83 and Glu 81, located in the hinge region, and NU2058. Hydrogen bonds are drawn as dotted lines. Arrows pointing towards Phe 80 and Lys 89 indicate the orientation of the inhibitor within the active site.
Figure 2.
Figure 2. Binding of NU6094, NU6086 and NU6102 to T160pCDK2 -cyclinA. a, T160pCDK2 -cyclinA -NU6094 structure. Selected CDK2 residues are drawn in ball-and-stick representation, with carbon atoms colored green (inhibitor) and yellow (CDK2). The final 2F[o]-F[c] electron density contoured at 0.24 e^- Å-3 for NU6094 is included. Hydrogen bonds in all panels except (b) are denoted by dashed lines. b, NU6094 bound to the CDK2 active site. NU6094 is depicted as yellow CPK spheres. The CDK2 molecular surface is colored by atom type: carbon, oxygen and nitrogen atoms are green, red and blue, respectively. The figure illustrates the complementarity of the NU6094 anilino ring to the shape of the hydrophobic tunnel leading to the specificity surface. c, T160pCDK2 -cyclinA -NU6086 structure. NU6086 and selected CDK2 residues are rendered in ball-and stick-representation, with carbon atoms colored as in (a). Both conformers of the anilino ring (denoted I and II) are included. The final 2F[o]-F[c] electron density for NU6086 is contoured at 0.24 e^- Å-3. d, T160pCDK2 -cyclinA -NU6102 structure. NU6102 and selected CDK2 residues are rendered in ball-and-stick representation, with carbon atoms colored as in (a). The final 2F[o]-F[c] electron density for NU6102 is contoured at 0.24 e^- Å-3. e, NU6102 bound to the CDK2 active site. The CDK2 molecular surface is rendered in transparent gray so that interactions between the NU6102 sulfonamide group and the backbone nitrogen and side chain oxygen of Asp 86 are visible. Hydrogen bonds are depicted by dotted lines. NU6102 is rendered in ball and stick, with carbon atoms colored green.
The above figures are reprinted by permission from Macmillan Publishers Ltd: Nat Struct Biol (2002, 9, 745-749) copyright 2002.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer